Form 4: HealthStream Executive Vice President Kevin P. O'Hara Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Kevin P. O'Hara reports the vesting of restricted share units and subsequent tax withholding.
Summary
- On February 27, 2025, Kevin P. O'Hara, Executive Vice President of HealthStream Inc., reported transactions involving the company's stock.
- 2,610 common stock shares were acquired due to the vesting of restricted share units (RSUs) at a price of $0.
- 665 shares were withheld for payment of tax liability at a price of $32.37.
- The transactions changed O'Hara's direct holdings to 14,178 shares.
- The vesting of RSUs is contingent upon continued service and the achievement of certain performance criteria established annually by the Compensation Committee.
- 12,023 RSUs were granted with vesting dates ranging from February 27, 2026, to February 27, 2030, based on performance criteria for the periods January 1, 2025, through December 31, 2029.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices with performance-based incentives, suggesting a positive outlook on the executive's performance and company goals.
Positives
- The vesting of RSUs indicates that performance criteria were met for the relevant periods, suggesting positive performance by the executive and potentially the company.
- The grant of new RSUs aligns the executive's interests with those of the shareholders, incentivizing continued performance and value creation.
Risks
- The vesting of RSUs is contingent upon continued service and the achievement of performance criteria, so failure to meet these conditions could result in forfeiture of the unvested units.
- Tax liabilities arising from the vesting of RSUs can reduce the net benefit to the executive.
Future Outlook
The vesting of future RSUs is contingent upon continued service and the achievement of performance criteria established annually by the Compensation Committee, indicating a performance-based compensation structure.
Industry Context
Executive compensation through stock and RSU grants is a common practice in the healthcare technology industry to align management's interests with shareholder value and incentivize long-term performance.
Comparison to Industry Standards
- Stock-based compensation is a standard practice among publicly traded companies, including HealthStream's competitors in the healthcare technology sector.
- Companies like Cerner (now Oracle Health) and Allscripts also utilize RSUs and stock options as part of their executive compensation packages.
- The vesting schedules and performance criteria associated with these grants are typically aligned with industry benchmarks and company-specific goals.
Stakeholder Impact
- Shareholders may view the vesting of RSUs and the grant of new units as a positive sign, indicating that the executive is incentivized to drive company performance and increase shareholder value.
- Employees may see this as a positive sign of company performance.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | 15% of certain RSUs vested for the period January 1, 2023 through December 31, 2023. |
| 02/23/2025 | 20% of certain RSUs vested for the period January 1, 2024 through December 31, 2024; 10% of certain RSUs vested for the period July 1, 2024 through December 31, 2024. |
| 02/27/2025 | Date of stock transaction report; vesting of 2,610 shares and withholding of 665 shares for tax liability; grant of 12,023 RSUs. |
| 02/23/2026 | 15% of certain RSUs vest for the period January 1, 2025 through December 31, 2025. |
| 02/27/2026 | 15% of certain RSUs vest for the period January 1, 2025 through December 31, 2025. |
| 02/23/2027 | 20% of certain RSUs vest for the period January 1, 2026 through December 31, 2026. |
| 02/27/2027 | 20% of certain RSUs vest for the period January 1, 2026 through December 31, 2026. |
| 02/23/2028 | 25% of certain RSUs vest for the period January 1, 2027 through December 31, 2027. |
| 02/27/2028 | 20% of certain RSUs vest for the period January 1, 2027 through December 31, 2027. |
| 02/23/2029 | 30% of certain RSUs vest for the period January 1, 2028 through December 31, 2028. |
| 02/27/2029 | 20% of certain RSUs vest for the period January 1, 2028 through December 31, 2028. |
| 02/27/2030 | 25% of certain RSUs vest for the period January 1, 2029 through December 31, 2029. |
| 02/28/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.